Analysis of advanced lung cancer patients diagnosed following emergency admission

European Respiratory Journal

Volumn 45, Issue 4, 2015, Pages 1098-1107

  Fujimoto, Daichi ^a   Shimizu, Ryoko ^a   Morimoto, Takeshi ^a,b   Kato, Ryoji ^a   Sato, Yuki ^a   Kogo, Mariko ^a   Ito, Jiro ^a   Teraoka, Shunsuke ^a   Otoshi, Takehiro ^a   Nagata, Kazuma ^a   Nakagawa, Atsushi ^a   Otsuka, Kojiro ^a   Katakami, Nobuyuki ^a   Tomii, Keisuke ^a  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADENOCARCINOMA; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSED FOLLOWING EMERGENCY ADMISSION; FEMALE; GENE MUTATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CARCINOMA, NON-SMALL-CELL LUNG; COMPARATIVE STUDY; EMERGENCY HEALTH SERVICE; EVALUATION STUDY; FACTUAL DATABASE; FOLLOW UP; IMMUNOHISTOCHEMISTRY; JAPAN; LUNG NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL; TREATMENT OUTCOME; TUMOR INVASION;

AGED; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; DATABASES, FACTUAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84926434211     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00068114     Document Type: Article

References (35)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Ramalingam SS, Owonikoko TK, Khuri FR. Lung cancer: new biological insights and recent therapeutic advances. CA Cancer J Clin 2011; 61: 91-112.
3. Elliss-Brookes L, McPhail S, Ives A, et al. Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets. Br J Cancer 2012; 107: 1220-1226.
4. Public Health England. National Cancer Intelligence Network. www.ncin.org.uk/home Date last accessed: November 1, 2013.
5. Morgan HK, Hodgson L, Baldock E, et al. P195 Outcomes in emergency admissions with lung cancer: a 1-year perspective from a teaching hospital. Thorax 2011; 66: A146-A147.
6. Beckett P, Tata LJ, Hubbard RB. Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients - Analysis based on the National Lung Cancer Audit. Lung Cancer 2014; 83: 396-400.
7. Yamaguchi S, Ohguri T, Matsuki Y, et al. Palliative radiotherapy in patients with a poor performance status: the palliative effect is correlated with prolongation of the survival time. Radiat Oncol 2013; 8: 166.
8. Sabur NF, Chee A, Stather DR, et al. The impact of tunneled pleural catheters on the quality of life of patients with malignant pleural effusions. Respiration 2013; 85: 36-42.
9. Fujimoto D, Ueda H, Shimizu R, et al. Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis. Clin Exp Metastasis 2014; 31: 543-551.
10. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2: 706-714.
11. Nagai Y, Miyazawa HHuqun et al. Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 2005; 65: 7276-7282.
12. Blum TG, Rich A, Baldwin D, et al. The European initiative for quality management in lung cancer care. Eur Respir J 2014; 43: 1254-1277.
13. Gorham J, Ameye L, Berghmans T, et al. The lung cancer patient at the emergency department: a three-year retrospective study. Lung Cancer 2013; 80: 203-208.
14. Mayer DK, Travers D, Wyss A, et al. Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina. J Clin Oncol 2011; 29: 2683-2688.
15. Kotajima F, Kobayashi K, Sakaguchi H, et al. Lung cancer patients frequently visit the emergency room for cancer-related and -unrelated issues. Mol Clin Oncol 2014; 2: 322-326.
16. Meert AP, Sculier JP. Aetiological diagnosis of acute respiratory failure in critical care oncology. Eur Respir J 2013; 42: 299-301.
17. Berghmans T, Pasleau F, Paesmans M, et al. Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations. Eur Respir J 2012; 39: 9-28.
18. Neal RD, Allgar VL, Ali N, et al. Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes. Br J Gen Pract 2007; 57: 212-219.
19. Slatore CG, Cecere LM, Letourneau JL, et al. Intensive care unit outcomes among patients with lung cancer in the surveillance, epidemiology, and end results-medicare registry. J Clin Oncol 2012; 30: 1686-1691.
20. Bonomi MR, Smith CB, Mhango G, et al. Outcomes of elderly patients with stage IIIB-IV non-small cell lung cancer admitted to the intensive care unit. Lung Cancer 2012; 77: 600-604.
21. Soares M, Toffart AC, Timsit JF, et al. Intensive care in patients with lung cancer: a multinational study. Ann Oncol 2014; 25: 1829-1835.
22. Soares M, Darmon M, Salluh JI, et al. Prognosis of lung cancer patients with life-threatening complications. Chest 2007; 131: 840-846.
23. Soares M, Caruso P, Silva E, et al. Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med 2010; 38: 9-15.
24. Adam AK, Soubani AO. Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit. Eur Respir J 2008; 31: 47-53.
25. Azevedo LC, Caruso P, Silva UV, et al. Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: results from a prospective multicenter study. Chest 2014; 146: 257-266.
26. Toffart AC, Minet C, Raynard B, et al. Use of intensive care in patients with nonresectable lung cancer. Chest 2011; 139: 101-108.
27. Ellis PM. The importance of multidisciplinary team management of patients with non-small-cell lung cancer. Curr Oncol 2012; 19: S7-S15.
28. Jung H, Sinnarajah A, Enns B, et al. Managing brain metastases patients with and without radiotherapy: initial lessons from a team-based consult service through a multidisciplinary integrated palliative oncology clinic. Support Care Cancer 2013; 21: 3379-3386.
29. Kelley AS, Meier DE. Palliative care - a shifting paradigm. N Engl J Med 2010; 363: 781-782.
30. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733-742.
31. Lilenbaum RC. Treatment of advanced non-small-cell lung cancer in special populations. Oncology (Williston Park) 2004; 18: 1321-1325.
32. Azzoli CG, Baker S Jr, Temin S, et al. American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 2009; 27: 6251-6266.
33. Zukin M, Barrios CH, Pereira JR, et al. Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2. J Clin Oncol 2013; 31: 2849-2853.
34. Helbekkmo N, Strøm HH, Sundstrøm SH, et al. Chemotherapy and quality of life in NSCLC PS 2 patients. Acta Oncol 2009; 48: 1019-1025.
35. Morth C, Valachis A. Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: a literature-based meta-analysis of randomized studies. Lung Cancer 2014; 84: 209-214.